Botulinum toxin versus others alternative methods as an option for the management of patients with bruxism: Systematic review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i8.31152

Keywords:

Bruxism; Tooth grinding; Botulinum toxin; Botox; Botulinum toxin A; Botulinum toxin type A.

Abstract

Objective: To determine if botulinum toxin is effective as a treatment for adult patients diagnosed with bruxism according to RCT-type scientific articles that have been published from 2016 to 2021. Methodology: An electronic search was carried out between November 2021 and January 2022 through three digital databases (PubMed, Science Direct, Cochrane Library), using the keywords "Bruxism", "¨Teeth grinding", "Botulinum toxin" , “Botox”, “Botulinum toxin A”, “Botulinum toxin type A” combined through the Boolean equation “AND”. For this review, the PRISMA scientific tool was considered, articles published in the last 5 years, in English and Spanish, in adult patients with bruxism, RCT type and prospective comparing Botox with placebo or traditional methods were included. Results: Of 90 screened articles, 6 RCTs were included in the review. Of these, 3 studies compared the effectiveness of BTX with occlusal splints and the remaining 3 with placebo. No significant differences were found between both methods and a decrease in symptoms and episodes of bruxism was observed. Control sessions were carried out up to 12 months without reporting adverse effects. Conclusions: BTX and traditional methods are appropriate for the treatment of bruxism because they reduce symptoms and prevent the appearance or progression of clinical signs. Nevertheless; considering that the pathology is multifactorial, the ideal treatment should be multidisciplinary, including: psychological and neurological treatment, physical therapy, pharmacological treatment, BTX applications combined with occlusal splints and restorative treatments.

Author Biographies

Leslie Gabriela Rodas Andrade, Universidad de Cuenca

Estudiante de la Facultad de Odontología de la Universidad de Cuenca, Cuenca, Ecuador

María Estefanía Sánchez Orellana, Universidad de Cuenca

Estudiante de la Facultad de Odontología de la Universidad de Cuenca, Cuenca, Ecuador

María de Lourdes León Vintimilla, Universidad de Cuenca

DDS, Magister en Investigación de la Salud, Especialista en Rehabilitación Oral, Miembro del grupo de investigación de Rehabilitación Oral G.I.R.O, Docente titular, Departamento de Prostodoncia en Pre y Postgrado, Facultad de Odontología, Universidad de Cuenca, Cuenca, Ecuador

References

Ali, S. M., Alqutaibi, A. Y., Aboalrejal, A., & Elawady, D. M. (2021). Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trial. The Saudi Dental Journal, 33(8), 1004-1011. https://doi.org/10.1016/j.sdentj.2021.07.001

Alves, A. C., Alchieri, J. C., & Barbosa, G. A. S. (2013). Bruxism. Masticatory implications and anxiety. Acta Odontologica Latinoamericana: AOL, 26(1), 15-22.

Aoki, K. R. (2005). Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology, 26(5), 785-793. https://doi.org/10.1016/j.neuro.2005.01.017

Cahlin, B., Lindberg, C., & Dahlstrom, L. (2019). Cerebral palsy and bruxism: Effects of botulinum toxin injections—A randomized controlled trial. Clinical and experimental dental research, 5(5), 460‐468.

De la Torre Canales, G., Câmara-Souza, M. B., do Amaral, C. F., Garcia, R. C. M. R., & Manfredini, D. (2017). Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clinical Oral Investigations, 21(3), 727-734. https://doi.org/10.1007/s00784-017-2092-4

Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina Oral, Patología Oral y Cirugía Bucal, 24(4), e416-e424. https://doi.org/10.4317/medoral.22923

Fuster Torres, M. A., Berini Aytés, L., & Gay Escoda, C. (2007). Salivary gland application of botulinum toxin for the treatment of sialorrhea. Medicina Oral, Patologia Oral Y Cirugia Bucal, 12(7), E511-517.

Gonzáles de Dios, J., Bruñel, J., & Aparicio, M. (2011). Listas guía de comprobación de revisiones sistemáticas y metaanálisis: Declaración PRISMA. Evidencias en Pediatría, 7(97).

Hernández Reyes, B., Díaz Gómez, S. M., Hidalgo Hidalgo, S., & Lazo Nodarse, R. (2017). Bruxismo: Panorámica actual. Revista Archivo Médico de Camagüey, 21(1), 913-930.

Ihde, S. K. A., & Konstantinovic, V. S. (2007). The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: An evidence-based review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 104(2), e1-11. https://doi.org/10.1016/j.tripleo.2007.02.004

Kaya, D., & Ataoglu, H. (2021). Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study. Nigerian journal of clinical practice, 24(3), 412‐417. https://doi.org/10.4103/njcp.njcp_251_20

Lee, W.-K., Bae, J.-H., Hu, K.-S., Kato, T., & Kim, S.-T. (2017). Anatomical recommendations for safe botulinum toxin injection into temporalis muscle: A simplified reproducible approach. Surgical and Radiologic Anatomy: SRA, 39(3), 263-269. https://doi.org/10.1007/s00276-016-1739-1

Lobbezoo, F., Ahlberg, J., Glaros, A. G., Kato, T., Koyano, K., Lavigne, G. J., de Leeuw, R., Manfredini, D., Svensson, P., & Winocur, E. (2013). Bruxism defined and graded: An international consensus. Journal of Oral Rehabilitation, 40(1), 2-4. https://doi.org/10.1111/joor.12011

Lobbezoo, F., Ahlberg, J., Raphael, K. G., Wetselaar, P., Glaros, A. G., Kato, T., Santiago, V., Winocur, E., De Laat, A., De Leeuw, R., Koyano, K., Lavigne, G. J., Svensson, P., & Manfredini, D. (2018). International consensus on the assessment of bruxism: Report of a work in progress. Journal of oral rehabilitation, 45(11), 837-844. https://doi.org/10.1111/joor.12663

Muñoz Lora, V. R. M., Del Bel Cury, A. A., Jabbari, B., & Lacković, Z. (2019). Botulinum Toxin Type A in Dental Medicine. Journal of Dental Research, 98(13), 1450-1457. https://doi.org/10.1177/0022034519875053

Ohayon, M. M., Li, K. K., & Guilleminault, C. (2001). Risk factors for sleep bruxism in the general population. Chest, 119(1), 53-61. https://doi.org/10.1378/chest.119.1.53

Ondo, W. G., Simmons, J. H., Shahid, M. H., Hashem, V., Hunter, C., & Jankovic, J. (2018). Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology, 90(7), e559-e564. https://doi.org/10.1212/WNL.0000000000004951

Patel, J., Cardoso, J. A., & Mehta, S. (2019). A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. British Dental Journal, 226(9), 667-672. https://doi.org/10.1038/s41415-019-0257-z

Pirazzini, M., Rossetto, O., Eleopra, R., & Montecucco, C. (2017). Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacological Reviews, 69(2), 200-235. https://doi.org/10.1124/pr.116.012658

Purkiss, J., Welch, M., Doward, S., & Foster, K. (2000). Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms. Biochemical Pharmacology, 59(11), 1403-1406. https://doi.org/10.1016/s0006-2952(00)00260-4

Rao, L. B., Sangur, R., & Pradeep, S. (2011). Application of Botulinum toxin type A: An arsenal in dentistry. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research, 22(3), 440-445. https://doi.org/10.4103/0970-9290.87068

Sellin, L. C., & Thesleff, S. (1981). Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction. The Journal of Physiology, 317, 487-495.

Shim, Y. J., Lee, H. J., Park, K. J., Kim, H. T., Hong, I. H., & Kim, S. T. (2020). Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial. Toxins, 12(3), E168. https://doi.org/10.3390/toxins12030168

Weill Medical College of Cornell University. (2021). Comparison of Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles in the Management of Myofascial Pain Disorder: A Randomized Clinical Trial (Clinical trial registration N.o NCT03223298). clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT03223298

Yurttutan, M. E., Tütüncüler Sancak, K., & Tüzüner, A. M. (2019). Which Treatment Is Effective for Bruxism: Occlusal Splints or Botulinum Toxin? Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons, 77(12), 2431-2438.

https://doi.org/10.1016/j.joms.2019.06.005

Published

26/06/2022

How to Cite

RODAS ANDRADE, L. G.; SÁNCHEZ ORELLANA, M. E.; LEÓN VINTIMILLA, M. de L. Botulinum toxin versus others alternative methods as an option for the management of patients with bruxism: Systematic review. Research, Society and Development, [S. l.], v. 11, n. 8, p. e47011831152, 2022. DOI: 10.33448/rsd-v11i8.31152. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/31152. Acesso em: 25 apr. 2024.

Issue

Section

Health Sciences